MEA Cell Based Assay Market

MEA Cell-Based Assay Market Size (2024 to 2029)

The size of the Cell-Based Assay Market in the Middle East & Africa was worth USD 1.10 billion in 2024 and estimated to be growing at a CAGR of 11.02%, to reach USD 1.85 billion by 2029.

Cell-based assays have a broad range of applications in basic research, drug discovery and ADME studies and it has a vital role in the pharmaceutical and biotechnology companies, academic institutions, and CROs for these applications. Cell-based assays provide a precise representation of the real-life model and the advantage of a dynamic experiment through monitoring the behaviour of the live cells. Cell-based assays are highly used in drug discovery and toxicity testing.

The primary driver for this market is the widespread use of cell-based assays in drug discovery processes. Cell-based assays market is emerging mainly due to an increase in activities like drug discovery, government expenditure and technological advancement.

Conversely, high cost associated with the instruments and process, lack of skilled professionals and rigid intellectual property rights are major factors restraining the market growth.

This research report segmented and sub-segmented into the following categories:

• By Type Of Product: Cell Lines, Assay Ready Kits, Cell Culture Kits, Reagents & Consumables And Ligands & Inhibitors
• By Technology: Automated Handling, Flow Cytometry, Label-Free Detection, High Content Screening and High Throughput Screening
• By Application: Drug Discovery and ADME Research
• By End Users: Academia, Biotechnology, Pharmaceuticals And CRO
• By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Regionally, Middle-East is leading the market, and Africa is estimated to grow at the highest CAGR in the forecast period. Increasing research activities for drug discovery, increasing stimulation of biological drugs and advance technological developments are driving the MEA market.

Africa is expected to grow with the highest CAGR of the cell-based assay market during the review period. The growth is attributed due to the factors such as the amount spent by the government for research and development towards the cell-based assay is another factor fuelling the market. The growing occurrence rate of cancer and other chronic diseases, rheumatoid arthritis of Africa in this MEA region is boosting the market growth.

Major companies in the MEA Cell-Based Assay Market profiled in this report are Thermo Fisher Scientific Inc., Becton & Dickinson and Company, Merck & Co. Inc., Cell Signalling Technology Inc., PerkinElmer Inc., Danaher Corporation, General Electric Company, Cisbio Bioassays, DiscoveRx, Ametek Inc., Bio-Rad Laboratories, Roche Diagnostics, GE Healthcare and Promega Corporation.